Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc (DNA) Covered Calls
Ginkgo Bioworks Holdings Inc trades in the Biotechnology industry with an IV Rank of 51.59%, average versus the past year. DNA's highest covered call setup is the $12.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 24.87% out of the money with 7 days to expiration, a 25.39% return until expiration, and a 1,323.92% theoretical annualized return. Across the setups shown, annualized returns run from 408.15% to 1,323.92% at strikes between $12.00 and $30.00, with 7 to 189 days to expiration, as of Nov 13, 2026.
Read more
Running DNA covered calls helps you generate income from Ginkgo Bioworks Holdings Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best DNA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If DNA stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling DNA covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given DNA covered call is worth writing.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| 2026-11-20 | 7 | 12.00 | 24.87 | 0.05 | 0.15 | 244.00 | 25.39 | 1323.92 | -0.52 | +0.13 | 616 | 0.10 |
| 2026-12-18 | 35 | 16.00 | 66.49 | 0.05 | 0.15 | 644.00 | 67.01 | 698.86 | -0.52 | +0.08 | 1,969 | 0.10 |
| 2027-01-15 | 63 | 20.00 | 108.12 | 0.05 | 0.25 | 1044.00 | 108.64 | 629.40 | -0.52 | +0.09 | 708 | 0.20 |
| 2026-12-18 | 35 | 15.00 | 56.09 | 0.10 | 0.35 | 549.00 | 57.13 | 595.76 | -1.04 | +0.15 | 11,052 | 0.25 |
| 2026-12-18 | 35 | 14.00 | 45.68 | 0.10 | 0.30 | 449.00 | 46.72 | 487.25 | -1.04 | +0.15 | 1,916 | 0.20 |
| 2027-03-19 | 126 | 25.00 | 160.15 | 0.10 | 0.45 | 1549.00 | 161.19 | 466.93 | -1.04 | +0.12 | 32 | 0.35 |
| 2027-01-15 | 63 | 17.00 | 76.90 | 0.05 | 0.45 | 744.00 | 77.42 | 448.54 | -0.52 | +0.14 | 120 | 0.40 |
| 2027-03-19 | 126 | 24.00 | 149.74 | 0.10 | 0.50 | 1449.00 | 150.78 | 436.78 | -1.04 | +0.13 | 43 | 0.40 |
| 2027-05-21 | 189 | 30.00 | 212.17 | 0.20 | 0.65 | 2059.00 | 214.26 | 413.77 | -2.08 | +0.15 | 3 | 0.45 |
| 2027-03-19 | 126 | 23.00 | 139.33 | 0.15 | 0.70 | 1354.00 | 140.89 | 408.15 | -1.56 | +0.17 | 0 | 0.55 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank51.59% Moderate
- Market cap (M$)539
- 52 weeks high-54.34%
- 52 weeks low54.93%
- Analyst recommendationSell
4.33 - Target price$8.00
-3.85% below the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-4.63
- EPS growth next 5 years16.87%
As of Nov 17, 2026